These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9549821)

  • 21. [Chance for prolonging life and decreasing the quality of life by intensive chemotherapy].
    Schreml W
    Verh Dtsch Ges Inn Med; 1986; 92():439-46. PubMed ID: 3028005
    [No Abstract]   [Full Text] [Related]  

  • 22. Multi-level models for repeated measurement data: application to quality of life data in clinical trials.
    Beacon HJ; Thompson SG
    Stat Med; 1996 Dec; 15(24):2717-32. PubMed ID: 8981682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).
    Bernhard J; Hürny C; Bacchi M; Joss RA; Cavalli F; Senn HJ; Leyvraz S; Stahel R; Ludwig C; Alberto P
    Br J Cancer; 1996 Nov; 74(10):1660-7. PubMed ID: 8932352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suggestions for the presentation of quality of life data from clinical trials.
    Machin D; Weeden S
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):711-24. PubMed ID: 9549818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
    D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
    BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.
    Buyse M; Thirion P; Carlson RW; Burzykowski T; Molenberghs G; Piedbois P;
    J Natl Cancer Inst; 2001 Mar; 93(5):399-401. PubMed ID: 11238707
    [No Abstract]   [Full Text] [Related]  

  • 27. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089).
    Rittmeyer A; Gorbunova V; Vikström A; Scherpereel A; Kim JH; Ahn MJ; Chella A; Chouaid C; Campbell AK; Barlesi F
    J Thorac Oncol; 2013 Nov; 8(11):1409-16. PubMed ID: 24077452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
    Han BH; Xiu QY; Wang HM; Shen J; Gu AQ; Luo Y; Bai CX; Guo SL; Liu WC; Zhuang ZX; Zhang Y; Zhao YZ; Jiang LY; Shi CL; Jin B; Zhou JY; Jin XQ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):854-9. PubMed ID: 22335953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model.
    Morita S; Kobayashi K; Eguchi K; Matsumoto T; Shibuya M; Yamaji Y; Sakamoto J; Ohashi Y
    Jpn J Clin Oncol; 2003 Sep; 33(9):470-6. PubMed ID: 14594941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analyzing longitudinal data with patients in different disease states during follow-up and death as final state.
    le Cessie S; de Vries EG; Buijs C; Post WJ
    Stat Med; 2009 Dec; 28(30):3829-43. PubMed ID: 19876950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Maintenance chemotherapy in small cell lung cancer: reasons for not using it].
    Jacoulet P
    Rev Pneumol Clin; 1998 Jul; 54(3):109-16. PubMed ID: 9769996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surrogate outcomes in quality-of-life research: where will we end up?
    Tassinari D; Panzini I; Sartori S; Ravaioli A
    J Clin Oncol; 2003 May; 21(9):1894-5; author reply 1895. PubMed ID: 12721275
    [No Abstract]   [Full Text] [Related]  

  • 33. Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.
    Hahn EA; Webster KA; Cella D; Fairclough DL
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):547-59. PubMed ID: 9549804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Missing patient-reported outcome data in an adjuvant lung cancer study.
    Land SR
    J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum duration of treatment with combination chemotherapy for small cell lung cancer.
    Cullen MH
    Chest; 1989 Jul; 96(1 Suppl):62S-64S. PubMed ID: 2544365
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial.
    Geddes DM; Dones L; Hill E; Law K; Harper PG; Spiro SG; Tobias JS; Souhami RL
    Eur J Cancer; 1990 Apr; 26(4):484-92. PubMed ID: 2162692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.
    James LE; Gower NH; Rudd RM; Spiro SG; Harper PG; Trask CW; Partridge M; Ruiz de Elvira MC; Souhami RL
    Br J Cancer; 1996 Jun; 73(12):1563-8. PubMed ID: 8664131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missing quality of life data in cancer clinical trials: serious problems and challenges.
    Bernhard J; Cella DF; Coates AS; Fallowfield L; Ganz PA; Moinpour CM; Mosconi P; Osoba D; Simes J; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):517-32. PubMed ID: 9549801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.